Status:
COMPLETED
Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma
Lead Sponsor:
Eisai Co., Ltd.
Conditions:
Malignant Glioma
Eligibility:
All Genders
Brief Summary
The objective of this study is to determine the survival status of patients enrolled in study GLI01S (all-case observational study).
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Malignant Glioma, patients enrolled in study GLI01S.
- Exclusion criteria:
- Corresponding to contraindication of Gliadel.
- Not applicable to indications of Gliadel.
Exclusion
Key Trial Info
Start Date :
January 10 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 10 2016
Estimated Enrollment :
507 Patients enrolled
Trial Details
Trial ID
NCT02300506
Start Date
January 10 2014
End Date
July 10 2016
Last Update
November 5 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Osaka, Japan
2
Tokyo, Japan